Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL

Clinical trial NCT07749365 · RECRUITING

Trial details

NCT number

NCT07749365

Sponsor

The First Affiliated Hospital of Xiamen University

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2026-07-25

Primary completion

2029-12-31

Enrollment

53

View on ClinicalTrials.gov